sphingotec GmbH

Mar 14, 2019

sphingotec announces new data on the kidney function marker pro-enkephalin (penKid®) presented at 24th International Conference on Advances in Critical Care Nephrology

Feb 15, 2019

Medical leaders back clinical utility of sphingotec's blood biomarker bio-ADM®

Oct 08, 2018

sphingotec raises EUR20 million from HBM and Wellington Partners

May 22, 2018

sphingotec is Adding an Advanced POC Testing Platform to Portfolio

Dec 07, 2017

Ortho Clinical Diagnostics and Sphingotec Announce Strategic Agreement Regarding Novel Biomarker for Decreasing Re-hospitalizations in Heart Failure

Dec 07, 2017

Ortho Clinical Diagnostics and Sphingotec Announce Strategic Agreement Regarding Novel Biomarker for Decreasing Re-hospitalizations in Heart Failure

Dec 01, 2017

sphingotec Announces Collaboration with Mayo Clinic for Evaluation and Use of Biomarkers to Improve Diagnosis of Certain Diseases, Including Kidney Disease, Breast Cancer, Sepsis, and Cardiovascular Disease